The global healthcare and laboratory labels market is to be worth US$ 9.59 billion in 2023 and US$ 14.89 billion by 2033, growing at a 4.5% CAGR between 2023 and 2033. The market is likely to grow at a 4.1% annual pace by 2023.
The rising demand for pharmaceutical products, as well as the launch of new products, may drive market expansion in the near future. The pressure-sensitive labels and labeling tapes sector is to grow much faster than all other industries in terms of rising labeling demand.
During the course of the forecast period, factors such a high frequency of diseases, an increase in hospital admissions, and an increase in product launches are to fuel market revenue growth. In the healthcare and pharmaceutical industries, labels are crucial. In numerous clinical cares, administrative, and operational domains, medical laboratory labels and laboratory equipment are utilized to improve patient safety.
There are numerous medical laboratory labels available to streamline workflow, increase effectiveness and patient safety, lessen mistakes, secure and manage medical data, and organize patient records and paperwork. The medical laboratory labels are utilized to track instruments and other assets like medical equipment.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As its name suggests, the UDI (Unique Device Identification) is a method used to identify and mark medical equipment across the healthcare supply chain. A system for uniquely identifying devices was mandated by the US FDA in order to properly identify devices during distribution and usage. Each UDI shall be made available in plain text and in an automated identification and data capture (AIDC) format.
A device that is intended for more than one use must be directly tagged with the UDI and reprocessed before each use. Device medical laboratory labels and packages must display dates in a uniform manner that adheres to accepted international standards.
Additionally, by advocating for harmonized legislation for Unique Device Identification (UDI), based on international standards, The IMDRF (International Medical Device Regulator Forum) and the European Commission are focusing on a globally consistent and unified approach that is to improve patient safety.
The adoption and integration of UDIs into the health care delivery system may allow for the full realization of the benefits that the unique device identification system offers. The use of UDI is to increase patient safety and promote medical device innovation.
Clinical mobility is going to be the answer to easing the strain on the healthcare system and enhancing patient care throughout the forecasted period. It is predicted that using technology may replace manual and prone to error processes in the healthcare and laboratory labeling industries. This may improve general visibility and the precision of patient identification escalating the healthcare and laboratory labels market trends.
The precision of patient identification and the efficiency of procedures can both be improved by the use of digital technologies. By sending the data to the clinical team in real time, it is also possible to raise visibility overall and improve the standard of patient care. This can yield crucial time savings by reducing or even eliminating errors.
| Attributes | Details |
|---|---|
| Healthcare and Laboratory Labels Market CAGR (From 2023 to 2033) | 4.5% |
| Healthcare and Laboratory Labels Market CAGR (From 2017 to 2022) | 4.4% |
| Healthcare and Laboratory Labels Market Size (2023) | US$ 9.59 billion |
| Healthcare and Laboratory Labels Market Size (2033) | US$ 14.89 billion |
| Global Market Y-o-Y Growth | 4.1% |
The onus is on the continued growth of medical devices
Medical device labeling assists patients and caretakers in understanding the device, its functioning and maintenance, how it interacts with the body to achieve its goal, and any safety or disposal issues. Medical device labeling is critical for ensuring the safe and effective use of equipment. It informs patients or caretakers about the device's correct use, hazards, and benefits in language they can comprehend.
Appropriate operation instructions are required to ensure that the gadgets are safe and functional. For example, as more patients utilize complex medical equipment at home, medical device labeling becomes important to effectively communicate with the person operating the device.
Medical device and healthcare and laboratory labels manufacturers are constantly looking for innovative products, which is why they invest considerably in research and development. The medical industry's rivalry is also forcing firms to invest extensively in research and development for new or updated technologies. A surge in new discoveries and formulations is driving up global demand for medical-grade laboratory labels.
Brazil, for example, has a considerable development potential in South America, whilst Poland, Hungary, and Russia contribute significantly to the European medical device market.
Due to the possibility of global clinical trials and experimentation, the medical industry is rapidly embracing medical device labeling. As a result, it is necessary to print instructions by laboratory labels printer in several languages about tracing medical devices as well as storage, transportation, and handling.
Principal Consultant
Millennials are becoming more trend-oriented with each passing decade. Healthcare brands should brace themselves for millennial attitudes and habits around how consumers research and consume healthcare items before making purchasing decisions.
People like to interact with firms that promote open transparency by tackling socioeconomic and environmental challenges. This provides the brand owner with a huge opportunity to try something new, such as app-based labeling solutions, which can readily locate detailed information about the product. This brings out new healthcare and laboratory labels market opportunities.
To arrest the momentum, government regulations must be stringent.
Healthcare and laboratory labeling has become problematic for healthcare and laboratory label manufacturers for a variety of reasons, including government rules to assure compliance, greater competent authority surveillance, language needs, and others.
Medical device labeling has become one of the most onerous difficulties for healthcare and laboratory label manufacturers, owing to various countries' emphasis on national language. Legal issues arise when medical devices and diagnostics are to be sold in both EU and non-EU countries. Labels have limited space and must contain a lot of information. Translations may be required to be technically correct, but they are usually literal.
The standard specifies that markings be placed directly on specific medical devices. In vitro diagnostic (IVD) businesses are considering using separate non- United States and United States labeling. The labels in the United States may be devoid of symbols, whereas the labels in the rest of the globe may include symbols. Labeling is an important component of a device, and there are extensive standards for marking and labeling.
When these medical-grade laboratory labels do not comply with US FDA rules, the products are considered misbranded, fraudulently labeled, or deceptive, including marketing for unapproved applications. As a result, pressure-sensitive labels and labeling tapes must meet all basic standards, or face fines for noncompliance with the regulations.
Medical device labels makers are additionally constrained by the constantly shifting needs of end users in relation to the materials, dimensions, printing, etc. of medical-grade laboratory labels. State restrictions, text font formats, and variable data printing could have a negative impact on the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Segment | Pharmaceutical |
|---|---|
| Market Size - 2023 | US$ 4,924.7 million |
| Market Share - 2023 | 30.1% |
| HCAGR (2017 to 2022) | 4.6% |
| CAGR (2023 to 2033) | 4.7% |
| Segment | Nutraceutical |
|---|---|
| Market Size - 2023 | US$ 3,299.1 million |
| Market Share - 2023 | 20.2% |
| HCAGR (2017 to 2022) | 4.9% |
| CAGR (2023 to 2033) | 5.0% |
| Segment | Medical Devices |
|---|---|
| Market Size - 2023 | US$ 2,588.2 million |
| Market Share - 2023 | 15.8% |
| HCAGR (2017 to 2022) | 3.3% |
| CAGR (2023 to 2033) | 3.6% |
| Segment | Blood Bank |
|---|---|
| Market Size - 2023 | US$ 1,759.2 million |
| Market Share - 2023 | 10.7% |
| HCAGR (2017 to 2022) | 3.8% |
| CAGR (2023 to 2033) | 3.9% |
| Segment | Hospital Services |
|---|---|
| Market Size - 2023 | US$ 1,330.8 million |
| Market Share - 2023 | 8.1% |
| HCAGR (2017 to 2022) | 4.2% |
| CAGR (2023 to 2033) | 4.3% |
| Segment | Laboratory |
|---|---|
| Market Size - 2023 | US$ 2,467.4 million |
| Market Share - 2023 | 15.1% |
| HCAGR (2017 to 2022) | 5.3% |
| CAGR (2023 to 2033) | 5.4% |
The many end-users influence the demand for healthcare and laboratory labelling. The demand for healthcare and laboratory labels is projected to be driven by end users such as pharmaceuticals, nutraceuticals, medical devices, blood banks, hospital services, and laboratories.
Demographic developments and socioeconomic changes are increasing strains on health systems and necessitating innovative approaches to healthcare delivery. The ageing of populations in both emerging and developed countries is increasing demand for healthcare.
Substantial rise in the middle-class population has resulted in faster urbanisation and more access to middle-class amenities. This is likely to encourage sedentary lifestyle changes, which may eventually lead to an increase in the prevalence of obesity, diabetes, and other costly health disorders, necessitating more healthcare and laboratory labelling.
| Segment | Polyolefin |
|---|---|
| Market Size - 2023 | US$ 4,024.8 million |
| Market Share - 2023 | 24.6% |
| HCAGR (2017 to 2022) | 4.9% |
| CAGR (2023 to 2033) | 5.0% |
| Segment | PET |
|---|---|
| Market Size - 2023 | US$ 652.3 million |
| Market Share - 2023 | 4.0% |
| HCAGR (2017 to 2022) | 3.9% |
| CAGR (2023 to 2033) | 4.0% |
| Segment | PVC |
|---|---|
| Market Size - 2023 | US$ 334.6 million |
| Market Share - 2023 | 2.0% |
| HCAGR (2017 to 2022) | 4.8% |
| CAGR (2023 to 2033) | 3.9% |
| Segment | Paper |
|---|---|
| Market Size - 2023 | US$ 10,630.4 million |
| Market Share - 2023 | 64.9% |
| HCAGR (2017 to 2022) | 4.4% |
| CAGR (2023 to 2033) | 4.5% |
| Segment | Others |
|---|---|
| Market Size - 2023 | US$ 727.1 million |
| Market Share - 2023 | 4.4% |
| HCAGR (2017 to 2022) | 2.8% |
| CAGR (2023 to 2033) | 3.2% |
Paper-based labels are predicted to be the popular material type in the healthcare and laboratory labels market, accounting for 64.9% of the value, due to their ease of availability and low cost.
The paper segment is to grow at a 4.5% CAGR during the forecast period, owing to rising demand for paper labels due to their widespread availability, light weight, low manufacturing costs, and eco-friendly nature, as well as a growing preference for recyclable products to address rising plastic pollution and environmental concerns.
Polyolefin-based labels are predicted to grow at a 5% CAGR between 2023 and 2033, owing to rising demand in nutraceutical applications due to their high adhesiveness. In 2023, the segment is to have a market share of 24.6%.
| Country | North America |
|---|---|
| HCAGR (From 2017 to 2022) | 3.7% |
| CAGR (From 2023 to 2033) | 3.7% |
| Market Size - 2023 | US$ 4,321.4 million |
| Market Share - 2023 | 26.4% |
| Country | Latin America |
|---|---|
| HCAGR (From 2017 to 2022) | 4.7% |
| CAGR (From 2023 to 2033) | 4.7% |
| Market Size - 2023 | US$ 958.0 million |
| Market Share - 2023 | 5.9% |
| Country | Europe |
|---|---|
| HCAGR (From 2017 to 2022) | 3.0% |
| CAGR (From 2023 to 2033) | 3.0% |
| Market Size - 2023 | US$ 3,166.2 million |
| Market Share - 2023 | 19.3% |
| Country | South East Asia |
|---|---|
| HCAGR (From 2017 to 2022) | 7.2% |
| CAGR (From 2023 to 2033) | 7.2% |
| Market Size - 2023 | US$ 2,956.3 million |
| Market Share - 2023 | 18.1% |
| Country | East Asia |
|---|---|
| HCAGR (From 2017 to 2022) | 4.8% |
| CAGR (From 2023 to 2033) | 4.8% |
| Market Size - 2023 | US$ 4,157.2 million |
| Market Share - 2023 | 25.4% |
SOUTH EAST ASIA:
| Country | India |
|---|---|
| HCAGR (From 2017 to 2022) | 7.5% |
| CAGR (From 2023 to 2033) | 7.4% |
| Market Size - 2023 | US$ 2,354.7 million |
| Market Share - 2023 | 79.6% |
| Country | Malaysia |
|---|---|
| HCAGR (From 2017 to 2022) | 6.1% |
| CAGR (From 2023 to 2033) | 5.6% |
| Market Size - 2023 | US$ 138.0 million |
| Market Share - 2023 | 4.7% |
EAST ASIA:
| Country | China |
|---|---|
| HCAGR (From 2017 to 2022) | 6.0% |
| CAGR (From 2023 to 2033) | 6.0% |
| Market Size - 2023 | US$ 2,332.0 million |
| Market Share - 2023 | 56.1% |
| Country | Japan |
|---|---|
| HCAGR (From 2017 to 2022) | 3.4% |
| CAGR (From 2023 to 2033) | 2.9% |
| Market Size - 2023 | US$ 1,131.5 million |
| Market Share - 2023 | 27.2% |
| Country | South Korea |
|---|---|
| HCAGR (From 2017 to 2022) | 3.4% |
| CAGR (From 2023 to 2033) | 3.6% |
| Market Size - 2023 | US$ 693.6 million |
| Market Share - 2023 | 17.8% |
In accordance with the increasing healthcare and laboratory labels market participants in the region, Europe and Asia Pacific account for the increase. The United Kingdom, Belgium, Denmark, Italy, Germany, and France lead Europe. In this region, the demand for innovative pharmaceuticals and nutraceuticals to improve healthcare services is projected to drive the development of new formulations and drugs.
This is predicted to drive the clinical research industry in NAFTA (North American Free Trade Agreement) countries, which may fuel the demand for healthcare and laboratory labels in the coming years. Rising population and increased medical tourism in nations such as India, China, Malaysia, and Thailand are raising optimism.
| Country | United States |
|---|---|
| HCAGR (From 2017 to 2022) | 3.6% |
| CAGR (From 2023 to 2033) | 3.7% |
| Market Size - 2023 | US$ 3,862.9 million |
| Market Share - 2023 | 89.5% |
| Country | Canada |
|---|---|
| HCAGR (From 2017 to 2022) | 4.3% |
| CAGR (From 2023 to 2033) | 3.5% |
| Market Size - 2023 | US$ 458.5 million |
| Market Share - 2023 | 10.5% |
Between 2023 and 2033, North America is to hold a significant revenue share in the global healthcare and laboratory labels market, thanks to factors like the region's advanced healthcare infrastructure and research facilities, an increase in clinical trials, and a rising need for accurate and dependable healthcare and laboratory labels in research facilities and laboratories.
Rising product releases, increased spending in medication discovery, and a focus on producing high-quality pressure-sensitive labels and labeling tapes are to fuel market revenue growth in North America.
| Country | Germany |
|---|---|
| HCAGR (From 2017 to 2022) | 3.5% |
| CAGR (From 2023 to 2033) | 3.6% |
| Market Size - 2023 | US$ 686.4 million |
| Market Share - 2023 | 21.7% |
| Country | Italy |
|---|---|
| HCAGR (From 2017 to 2022) | 3.6% |
| CAGR (From 2023 to 2033) | 3.4% |
| Market Size - 2023 | US$ 402.8 million |
| Market Share - 2023 | 12.7% |
| Country | France |
|---|---|
| HCAGR (From 2017 to 2022) | 1.9% |
| CAGR (From 2023 to 2033) | 2.0% |
| Market Size - 2023 | US$ 532.2 million |
| Market Share - 2023 | 16.8% |
| Country | United Kingdom |
|---|---|
| HCAGR (From 2017 to 2022) | 1.5% |
| CAGR (From 2023 to 2033) | 1.3% |
| Market Size - 2023 | US$ 451.9 million |
| Market Share - 2023 | 14.3% |
| Country | Spain |
|---|---|
| HCAGR (From 2017 to 2022) | 3.2% |
| CAGR (From 2023 to 2033) | 3.2% |
| Market Size - 2023 | US$ 278.4 million |
| Market Share - 2023 | 8.8% |
The European healthcare and laboratory labels market warned that growing demand for medical laboratory labels could be hampered by raw material shortages, supply chain conflicts, and ongoing strikes. Russia's invasion of Ukraine might further destabilize the supply of resources such as wood, as well as push up energy prices, with energy-intensive businesses such as paper and plastics - two of the key materials used in medical-grade laboratory labels- likely to suffer significantly.
This might mean that laboratory label printers may soon be unable to fulfill orders, with bottlenecks and label shortages potentially affecting critical businesses like pharmaceutical labeling in the forecast period.
Healthcare and laboratory label manufacturers are focusing their efforts on developing advanced, innovative solutions that comply with laws while also bringing value to the medical experience.
Manufacturers in this market are heavily focused on mergers and acquisitions in order to propel market expansion in the coming year. The healthcare and laboratory label manufacturers are also focusing on the launch of new products in order to establish and maintain a global presence.
Recent Development:
| Date | April 2021 |
|---|---|
| Company | Multi-Color Corporation (MCC) |
| Strategy | Acquisition |
| Details | Multi-Color Corporation (MCC), a major producer of label solutions for a variety of industries, purchased Herrods, an in-mold label solutions (IML) provider in Australia and New Zealand, in April 2021. This acquisition is intended to open up new potential for worldwide and local growth, as well as expand their product offering. |
| Date | January 2022 |
|---|---|
| Company | Loftware Inc. |
| Strategy | Acquisition |
| Details | Loftware Inc. announced the acquisition of PRISYM ID, a producer and distributor of regulated content and label management solutions for medical centres and laboratories, in January 2022. The acquisition is to broaden Loftware's labelling solutions for the medical device and pharmaceutical industries, as well as enhance its end-to-end, cloud-based labelling platform with PRISYM ID's sophisticated clinical trial labelling. |
| Date | March 2020 |
|---|---|
| Company | Schreiner Group |
| Strategy | Partnership |
| Details | Schreiner Group established a partnership with RIFD tracking solutions supplier Kit Check in March 2020 to develop RFID-based smart labelling solutions. |
In 2023, the market is anticipated to reach a worth of US$ 9.59 billion.
By 2033, the industry is anticipated to have expanded to US$14.89 billion.
The market boosted at a HCAGR of 4.4% from 2018 to 2022.
The government must impose strict regulations in order to stop the momentum.
The market boosted at a HCAGR of 4.3% from 2018 to 2022.
1. Executive Summary | Healthcare and Laboratory Labels Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Square Meter) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Square Meter) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Material
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Square Meter) Analysis By Material, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Square Meter) Analysis and Forecast By Material, 2023 to 2033
5.3.1. Polyolefin
5.3.2. PET
5.3.3. PVC
5.3.4. Paper
5.3.5. Others
5.4. Y-o-Y Growth Trend Analysis By Material, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Material, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-user
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Square Meter) Analysis By End-user, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Square Meter) Analysis and Forecast By End-user, 2023 to 2033
6.3.1. Pharmaceuticals
6.3.2. Nutraceuticals
6.3.3. Medical Devices
6.3.4. Blood Banks
6.3.5. Hospital Services
6.3.6. Laboratories
6.4. Y-o-Y Growth Trend Analysis By End-user, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By End-user, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) & Volume (Square Meter) Analysis By Region, 2018 to 2022
7.3. Current Market Size Value (US$ Million) & Volume (Square Meter) Analysis and Forecast By Region, 2023 to 2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
8.1. Historical Market Size Value (US$ Million) & Volume (Square Meter) Trend Analysis By Market Taxonomy, 2018 to 2022
8.2. Market Size Value (US$ Million) & Volume (Square Meter) Forecast By Market Taxonomy, 2023 to 2033
8.2.1. By Country
8.2.1.1. The USA
8.2.1.2. Canada
8.2.2. By Material
8.2.3. By End-user
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Material
8.3.3. By End-user
8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Square Meter) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Square Meter) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Material
9.2.3. By End-user
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Material
9.3.3. By End-user
9.4. Key Takeaways
10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Square Meter) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Square Meter) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. United Kingdom
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Material
10.2.3. By End-user
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Material
10.3.3. By End-user
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Square Meter) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Square Meter) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Singapore
11.2.1.5. Thailand
11.2.1.6. Indonesia
11.2.1.7. Australia
11.2.1.8. New Zealand
11.2.1.9. Rest of Asia Pacific
11.2.2. By Material
11.2.3. By End-user
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Material
11.3.3. By End-user
11.4. Key Takeaways
12. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Square Meter) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Square Meter) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Material
12.2.3. By End-user
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Material
12.3.3. By End-user
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. USA
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2022
13.1.2.1. By Material
13.1.2.2. By End-user
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2022
13.2.2.1. By Material
13.2.2.2. By End-user
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2022
13.3.2.1. By Material
13.3.2.2. By End-user
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2022
13.4.2.1. By Material
13.4.2.2. By End-user
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2022
13.5.2.1. By Material
13.5.2.2. By End-user
13.6. United Kingdom
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2022
13.6.2.1. By Material
13.6.2.2. By End-user
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2022
13.7.2.1. By Material
13.7.2.2. By End-user
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2022
13.8.2.1. By Material
13.8.2.2. By End-user
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2022
13.9.2.1. By Material
13.9.2.2. By End-user
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2022
13.10.2.1. By Material
13.10.2.2. By End-user
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2022
13.11.2.1. By Material
13.11.2.2. By End-user
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2022
13.12.2.1. By Material
13.12.2.2. By End-user
13.13. Singapore
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2022
13.13.2.1. By Material
13.13.2.2. By End-user
13.14. Thailand
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2022
13.14.2.1. By Material
13.14.2.2. By End-user
13.15. Indonesia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2022
13.15.2.1. By Material
13.15.2.2. By End-user
13.16. Australia
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2022
13.16.2.1. By Material
13.16.2.2. By End-user
13.17. New Zealand
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2022
13.17.2.1. By Material
13.17.2.2. By End-user
13.18. GCC Countries
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2022
13.18.2.1. By Material
13.18.2.2. By End-user
13.19. South Africa
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2022
13.19.2.1. By Material
13.19.2.2. By End-user
13.20. Israel
13.20.1. Pricing Analysis
13.20.2. Market Share Analysis, 2022
13.20.2.1. By Material
13.20.2.2. By End-user
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Material
14.3.3. By End-user
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Avery Dennison Corporation
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.1.5.2. Product Strategy
15.1.1.5.3. Channel Strategy
15.1.2. CCL Industries Inc.
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.2.5.2. Product Strategy
15.1.2.5.3. Channel Strategy
15.1.3. 3M Company
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.3.5.2. Product Strategy
15.1.3.5.3. Channel Strategy
15.1.4. Multi-Color Corporation
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.4.5.2. Product Strategy
15.1.4.5.3. Channel Strategy
15.1.5. UPM Raflatac Corporation
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.5.5.2. Product Strategy
15.1.5.5.3. Channel Strategy
15.1.6. Brady Corporation
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.6.5.2. Product Strategy
15.1.6.5.3. Channel Strategy
15.1.7. Sato Holdings Corporation
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.7.5.2. Product Strategy
15.1.7.5.3. Channel Strategy
15.1.8. Weber Packaging Solutions, Inc.
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.8.5.2. Product Strategy
15.1.8.5.3. Channel Strategy
15.1.9. Schreiner Group GmbH & Co. KG
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.9.5.2. Product Strategy
15.1.9.5.3. Channel Strategy
15.1.10. Diagramm Halbach GmbH & Co. KG
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.10.5.2. Product Strategy
15.1.10.5.3. Channel Strategy
15.1.11. The Aenova Group
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segments
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
15.1.11.5.2. Product Strategy
15.1.11.5.3. Channel Strategy
15.1.12. Shamrock Labels
15.1.12.1. Overview
15.1.12.2. Product Portfolio
15.1.12.3. Profitability by Market Segments
15.1.12.4. Sales Footprint
15.1.12.5. Strategy Overview
15.1.12.5.1. Marketing Strategy
15.1.12.5.2. Product Strategy
15.1.12.5.3. Channel Strategy
15.1.13. Medline Industries, Inc.
15.1.13.1. Overview
15.1.13.2. Product Portfolio
15.1.13.3. Profitability by Market Segments
15.1.13.4. Sales Footprint
15.1.13.5. Strategy Overview
15.1.13.5.1. Marketing Strategy
15.1.13.5.2. Product Strategy
15.1.13.5.3. Channel Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Packaging
February 2024
REP-GB-1446
200 pages
Explore Packaging Insights
View Reports
Healthcare and Laboratory Labels Market
